Document Detail


Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agent.
MedLine Citation:
PMID:  23318786     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Chemotherapeutic drugs are clinically used to treat cancer because of their cytotoxic activities against tumor cells. Recently, however, evidence is accumulating-including the report of Hervieu et al. (2012) in the current issue of The Journal of Investigative Dermatology-indicating that at least some of these drugs have broader activities and that they should also be considered immunomodulatory agents. Indeed, Hervieu demonstrates that dacarbazine (DTIC) exerts immunostimulatory effects by inducing local activation of natural killer (NK) and T cells, suggesting that upon treatment with DTIC, the tumor participates in the initiation of an immune response: (i) DTIC treatment elicits the expression of ligands of the immunoreceptor NKG2D on melanoma cells; (ii) engagement of the ligands by NKG2D on NK cells leads to their activation, allowing enhanced tumor-cell killing and the release of IFN-γ; and (iii) IFN-γ in turn upregulates major histocompatibility complex class I expression on tumor cells, which favors their recognition by cytotoxic CD8+ T lymphocytes (CTLs).
Authors:
Selma Ugurel; Annette Paschen; Jürgen C Becker
Related Documents :
21435846 - Anti-tumor efficacy of polymer-platinum(ii) complex micelles fabricated from folate con...
20647356 - In vivo imaging of tumors.
19893726 - Analysis of empty sella secondary to the brain tumors.
6481426 - Penetration of vp-16 (etoposide) into human intracerebral and extracerebral tumors.
22488716 - Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term...
11406656 - Protein overexpression and gene amplification of c-erb b-2 in pulmonary carcinomas: a c...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of investigative dermatology     Volume:  133     ISSN:  1523-1747     ISO Abbreviation:  J. Invest. Dermatol.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0426720     Medline TA:  J Invest Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  289-92     Citation Subset:  IM    
Affiliation:
1] Department of Dermatology, University of Würzburg, Würzburg, Germany [2] Division of General Dermatology, Medical University of Graz, Graz, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Psoriasis epidemiology: the interplay of genes and the environment.
Next Document:  Melanoma prognostics and personalized therapeutics at a crossroad.